Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 17, 2017 - Issue 3
Submit an article Journal homepage
902
Views
24
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle

Lorenzo GerratanaDepartment of Medical and Biological Sciences, University of Udine, Udine, Italy;Department Oncology, University Hospital of Udine, Udine, ItalyView further author information
,
Marta BonottoDepartment of Medical and Biological Sciences, University of Udine, Udine, Italy;Department Oncology, University Hospital of Udine, Udine, ItalyView further author information
,
Claudia BozzaDepartment of Medical and Biological Sciences, University of Udine, Udine, Italy;Department Oncology, University Hospital of Udine, Udine, ItalyView further author information
,
Elena OngaroDepartment of Medical and Biological Sciences, University of Udine, Udine, Italy;Department Oncology, University Hospital of Udine, Udine, ItalyView further author information
,
Valentina FanottoDepartment of Medical and Biological Sciences, University of Udine, Udine, Italy;Department Oncology, University Hospital of Udine, Udine, ItalyView further author information
,
Giacomo PelizzariDepartment of Medical and Biological Sciences, University of Udine, Udine, Italy;Department Oncology, University Hospital of Udine, Udine, ItalyView further author information
&
Fabio PuglisiDepartment of Medical and Biological Sciences, University of Udine, Udine, Italy;Department Oncology, University Hospital of Udine, Udine, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 365-374 | Received 16 Nov 2016, Accepted 12 Jan 2017, Published online: 30 Jan 2017

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Sophia Konig, Hannah Strobel, Michael Grunert, Marcin Lyszkiewicz, Oliver Brühl, Georg Karpel-Massler, Natalia Ziętara, Katia La Ferla-Brühl, Markus D. Siegelin, Klaus-Michael Debatin & Mike-Andrew Westhoff. (2022) Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressure. Expert Opinion on Drug Discovery 17:10, pages 1081-1094.
Read now
Sadra Samavarchi Tehrani, Saba Gharibi, Ahmad Movahedpour, Golnaz Goodarzi, Zeinab Jamali, Seyyed Hossein Khatami, Mahmoud Maniati, Maryam Ranjbar, Zahra Shabaninejad, Amir Savardashtaki & Mortaza Taheri-Anganeh. (2021) Design and evaluation of scFv-RTX-A as a novel immunotoxin for breast cancer treatment: an in silico approach. Journal of Immunoassay and Immunochemistry 42:1, pages 19-33.
Read now
Yi-Wei Tong, Gen Wang, Jia-Yi Wu, Ou Huang, Jian-Rong He, Li Zhu, Wei-Guo Chen, Ya-Fen Li, Xiao-Song Chen & Kun-Wei Shen. (2019) Insulin-like growth factor-1, metabolic abnormalities, and pathological complete remission rate in HER2-positive breast cancer patients receiving neoadjuvant therapy. OncoTargets and Therapy 12, pages 3977-3989.
Read now
Agnieszka Adamczyk, Anna Kruczak, Agnieszka Harazin-Lechowska, Aleksandra Ambicka, Aleksandra Grela-Wojewoda, Małgorzata Domagała-Haduch, Anna Janecka-Widła, Kaja Majchrzyk, Anna Cichocka, Janusz Ryś & Joanna Niemiec. (2018) Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment. OncoTargets and Therapy 11, pages 4525-4535.
Read now
Henry W. C. Leung, Agnes L. F. Chan, Chih-Hsin Muo & John Hang Leung. (2018) Cost-effectiveness of pertuzumab combined with trastuzumab and docetaxel as a first-line treatment for HER-2 positive metastatic breast cancer. Expert Review of Pharmacoeconomics & Outcomes Research 18:2, pages 207-213.
Read now

Articles from other publishers (19)

Medha Medha & Amit Roy. (2022) Microgravity: New aspect for breast cancer treatment, a review. Acta Astronautica 190, pages 62-73.
Crossref
Oladapo Olaleye, Baubek Spanov, Robert Ford, Natalia Govorukhina, Nico C. van de Merbel & Rainer Bischoff. (2021) Enrichment and Liquid Chromatography–Mass Spectrometry Analysis of Trastuzumab and Pertuzumab Using Affimer Reagents. Analytical Chemistry 93:40, pages 13597-13605.
Crossref
Alla Turshudzhyan & James Vredenburgh. (2021) Ado-trastuzumab emtansine: Avoiding side-effects of traditional HER2 positive breast cancer treatment. Journal of Oncology Pharmacy Practice 27:7, pages 1770-1774.
Crossref
Agnieszka Gornowicz, Wojciech Szymanowski, Robert Czarnomysy, Krzysztof Bielawski & Anna Bielawska. (2021) Anti-HER2 monoclonal antibodies intensify the susceptibility of human gastric cancer cells to etoposide by promoting apoptosis, but not autophagy. PLOS ONE 16:8, pages e0255585.
Crossref
Rakesh Kumar Dhritlahre & Ankit Saneja. (2021) Recent advances in HER2-targeted delivery for cancer therapy. Drug Discovery Today 26:5, pages 1319-1329.
Crossref
Andreia Gameiro, Catarina Nascimento, Jorge Correia & Fernando Ferreira. (2021) HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models. Cancers 13:9, pages 2007.
Crossref
Ivan Y. Filin, Valeriya V. Solovyeva, Kristina V. Kitaeva, Catrin S. Rutland & Albert A. Rizvanov. (2020) Current Trends in Cancer Immunotherapy. Biomedicines 8:12, pages 621.
Crossref
Juliette Sauveur, Louise Conilh, Sabine Beaumel, Kamel Chettab, Lars‐Petter Jordheim, Eva‐Laure Matera & Charles Dumontet. (2020) Characterization of T‐DM1‐resistant breast cancer cells. Pharmacology Research & Perspectives 8:4.
Crossref
Deborah B. Doroshow & James H. Doroshow. (2020) Genomics and the History of Precision Oncology. Surgical Oncology Clinics of North America 29:1, pages 35-49.
Crossref
Tatiana V. Komarova, Ekaterina V. Sheshukova, Ekaterina N. Kosobokova, Vyacheslav S. Kosorukov, Anastasia V. Shindyapina, Fedor A. Lipskerov, Polina S. Shpudeiko, Tatiana E. Byalik & Yuri L. Dorokhov. (2019) The biological activity of bispecific trastuzumab/pertuzumab plant biosimilars may be drastically boosted by disulfiram increasing formaldehyde accumulation in cancer cells. Scientific Reports 9:1.
Crossref
Nidhi Garg, Suman Baishnab, Rosy Das, Kiranjeet Kaur, Saurabh Gupta & Sandeep Arora. (2019) Insights of Breast Cancer & Barriers to its Therapy. Journal of Pharmaceutical Technology, Research and Management 7:2, pages 73-86.
Crossref
Javad Behravan, Atefeh Razazan & Ghazal Behravan. (2019) Towards Breast Cancer Vaccines, Progress and Challenges. Current Drug Discovery Technologies 16:3, pages 251-258.
Crossref
Deborah B. Doroshow & James H. Doroshow. (2019) From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development. The Cancer Journal 25:4, pages 245-253.
Crossref
Michael Ulm, Arvind V Ramesh, Keely M McNamara, Suriyan Ponnusamy, Hironobu Sasano & Ramesh Narayanan. (2019) Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers. Endocrine Connections 8:2, pages R10-R26.
Crossref
Giacomo Pelizzari, Lorenzo Gerratana, Debora Basile, Valentina Fanotto, Michele Bartoletti, Alessia Liguori, Caterina Fontanella, Simon Spazzapan & Fabio Puglisi. (2019) Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation. Cancer Treatment Reviews 72, pages 7-14.
Crossref
J. Posner, P. Barrington, T. Brier & A. Datta-Mannan. 2019. Concepts and Principles of Pharmacology. Concepts and Principles of Pharmacology 81 141 .
Mariam Abotaleb, Peter Kubatka, Martin Caprnda, Elizabeth Varghese, Barbora Zolakova, Pavol Zubor, Radka Opatrilova, Peter Kruzliak, Patrik Stefanicka & Dietrich Büsselberg. (2018) Chemotherapeutic agents for the treatment of metastatic breast cancer: An update. Biomedicine & Pharmacotherapy 101, pages 458-477.
Crossref
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref
R.V. Anatskyi, O.E. Kolomiitseva, M. Cretu & V. Potop. (2017) Methodical basis of training of cadets for the military applied heptathlon competitions. Physical education of students 21:6, pages 255.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.